Mabpharm Limited
HKEX:2181.HK
Overview | Financials
Company Name | Mabpharm Limited |
Symbol | 2181.HK |
Currency | HKD |
Price | 0.33 |
Market Cap | 1,360,946,400 |
Dividend Yield | 0% |
52-week-range | 0.25 - 0.55 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Hao Wang |
Website | https://www.mabpharm.cn |
An error occurred while fetching data.
About Mabpharm Limited
Mabpharm Limited, a biopharmaceutical company, engages in research, development, and production of drugs and biosimilar drugs for allergic diseases, cancers, and autoimmune diseases in China. Its products under the Phase III clinical trial include CMAB007, a recombinant humanized anti-IgE monoclonal antibody for treatment of asthma patients; CMAB009, a recombinant anti-EGFR
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD